Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Jersey Agency: Nurse Giving Flu Shots Reused Syringes

By Drug Discovery Trends Editor | October 8, 2015

A nurse administering flu shots to dozens of employees of a pharmaceutical company reused syringes, the state Department of Health said Wednesday.
 
There is a low risk of infection and syringes that hold the vaccine, not needles, were reused, they said. But state and local health officials, as well as the federal Centers for Disease Control and Prevention, are recommending testing for hepatitis B and C and HIV, which can spread via blood.
 
Officials said it happened Sept. 30 when a nurse with TotalWellness administered flu vaccines to 67 employees of Otsuka Pharmaceutical in West Windsor. It’s unclear whether the same syringe was used on multiple patients or if several of them were reused.
 
TotalWellness said the nurse was an independent contractor and that the company is working with officials to notify patients and provide resources for potential medical risks.
 
“We take full responsibility for this incident and are working diligently with the New Jersey Department of Health to resolve this matter as swiftly as possible,” TotalWellness president and founder Alan Kohll said in a statement. “Our sincerest apologies go out to all those affected by this terrible event.”
 
Otsuka Pharmaceutical said in statement it was alarmed at the breach and that employee health is its top concern.
 
The Board of Nursing said it was gathering information and taking steps to protect the public but did not elaborate.
 
Source: Associated Press

Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE